{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:50:07Z","timestamp":1762674607151,"version":"build-2065373602"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1991,8,1]],"date-time":"1991-08-01T00:00:00Z","timestamp":681004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1991,8,1]],"date-time":"1991-08-01T00:00:00Z","timestamp":681004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1991,8]]},"DOI":"10.1007\/bf00319734","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T09:42:31Z","timestamp":1662975751000},"page":"245-250","source":"Crossref","is-referenced-by-count":30,"title":["Ergotamine, flunarizine and sumatriptan do not change cerebral blood flow velocity in normal subjects and migraneurs"],"prefix":"10.1007","volume":"238","author":[{"given":"H.-C.","family":"Diener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Rudzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Noe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Dichgans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Haux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tfelt-Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00319734_CR1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1161\/01.STR.18.1.120","volume":"18","author":"AR Andersen","year":"1987","unstructured":"Andersen AR, Tfelt-Hansen P, Lassen NA (1987) The effect of ergotamine and dihydroergotamine or cerebral blood flow in man. Stroke 18:120\u2013123","journal-title":"Stroke"},{"key":"BF00319734_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1476-5381.1980.tb10410.x","volume":"68","author":"E Apperley","year":"1980","unstructured":"Apperley E, Feniuk W, Humphrey PPA, Levy GP (1980) Evidence for two types of excitatory receptor for 5-hydroxytryptamin in dog isolated vasculature. Br J Pharmacol 68:215\u2013224","journal-title":"Br J Pharmacol"},{"key":"BF00319734_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1476-5381.1990.tb14679.x","volume":"99","author":"MG Buzzi","year":"1990","unstructured":"Buzzi MG, Moskowitz MA (1990) The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 99:202\u2013206","journal-title":"Br J Pharmacol"},{"issue":"10","key":"BF00319734_CR4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/0333102489009S10187","volume":"9","author":"C Dahlof","year":"1989","unstructured":"Dahlof C, Winter P, Ludlow S (1989) Oral GR43175, a 5HT1-like agonist for treatment of the acute migraine attack: an international study \u2014 preliminary data. Cephalalgia 9 [Suppl 10]:351\u2013353","journal-title":"Cephalalgia"},{"volume-title":"Drug induced headache","year":"1988","key":"BF00319734_CR5","unstructured":"Diener HC, Wilkinson M (eds) (1988) Drug induced headache. Springer, Berlin Heidelberg New York"},{"key":"BF00319734_CR6","doi-asserted-by":"crossref","unstructured":"Diener HC, Haab J, Peters C, Ried S, Dichgans J, Pilgrim A (1991) Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache (in press)","DOI":"10.1111\/j.1526-4610.1991.hed3104205.x"},{"key":"BF00319734_CR7","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(88)92122-8","volume":"I","author":"A Doenicke","year":"1988","unstructured":"Doenicke A, Brand J, Perrin V (1988) GR43175, a novel 5-HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet I:1309\u20131311","journal-title":"Lancet"},{"key":"BF00319734_CR8","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1476-5381.1985.tb08948.x","volume":"86","author":"W Feniuk","year":"1985","unstructured":"Feniuk W, Humphrey PPA, Perren MJ, Watts AD (1985) A comparison of 5-hydroxytryptamin receptors mediating contraction in rabbit aorta and dog saphenous vein: evidence for different receptor types obtained by use of selective agonists and antagonists. Br J Pharmacol 86:697\u2013704","journal-title":"Br J Pharmacol"},{"issue":"10","key":"BF00319734_CR9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0333102489009S10185","volume":"9","author":"MD Ferrari","year":"1989","unstructured":"Ferrari MD, Bayliss EM, Ludlow S, Pilgrim AJ (1989) Subcutaneous GR43175 in the treatment of acute migraine: an international european study. Cephalalgia 9 [Suppl 10]:348\u2013349","journal-title":"Cephalalgia"},{"key":"BF00319734_CR10","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.STR.9.6.594","volume":"9","author":"V Hachinski","year":"1978","unstructured":"Hachinski V, Norris JW, Edmeads J, Cooper PW (1978) Ergotamine and cerebral blood flow. Stroke 9:594\u2013596","journal-title":"Stroke"},{"key":"BF00319734_CR11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1358\/dof.1989.014.01.76484","volume":"14","author":"PPA Humphrey","year":"1989","unstructured":"Humphrey PPA, Feniuk W, Perren MJ, Oxford AW, Brittain RT (1989) Sumatriptan succinate. Drugs Future 14:35\u201339","journal-title":"Drugs Future"},{"key":"BF00319734_CR12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00547560","volume":"23","author":"JJ Ibraheem","year":"1982","unstructured":"Ibraheem JJ, Paalzow J, Tfelt-Hansen P (1982) Kinetics of ergotamine after intravenous and intramuscular administration to migraine suffers. Eur J Clin Pharmacol 23:235\u2013240","journal-title":"Eur J Clin Pharmacol"},{"key":"BF00319734_CR13","unstructured":"Noe A (1989) Transkranielle Dopplersonographie: Normalwerte und Physiologische Variationen. MD thesis, University of T\u00fcbingen"},{"key":"BF00319734_CR14","first-page":"173","volume-title":"Handbook of clinical neurology, vol 4: Headache","author":"RC Peatfield","year":"1986","unstructured":"Peatfield RC, Fozard JR, Clifford Rose F (1986) Drug treatment of migraine. In: Clifford Rose F (ed) Handbook of clinical neurology, vol 4: Headache. Elsevier, Amsterdam, pp 173\u2013217"},{"key":"BF00319734_CR15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0166-2236(88)90011-2","volume":"11","author":"SJ Peroutka","year":"1988","unstructured":"Peroutka SJ (1988) 5-hydroxytryptamine receptor subtypes: molecular, biochemical and physiological characterization. Trends Neurol Sci 11:496\u2013500","journal-title":"Trends Neurol Sci"},{"key":"BF00319734_CR16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1055\/s-2008-1069578","volume":"108","author":"R Puzich","year":"1983","unstructured":"Puzich R, Girke W, Heidrich H, Rischke M (1983) Dopplersonographische Untersuchungen der extrakraniellen Hirngef\u00e4\u00dfe bei Migr\u00e4nepatienten nach Gabe von Ergotamintartrat. Dtsch Med Wochenschr 108:457\u2013461","journal-title":"Dtsch Med Wochenschr"},{"key":"BF00319734_CR17","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ana.410240607","volume":"24","author":"K Saito","year":"1988","unstructured":"Saito K, Markowitz S, Moskowitz MA (1988) Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 24:732\u2013737","journal-title":"Ann Neurol"},{"key":"BF00319734_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(74)90206-4","volume":"27","author":"PR Saxena","year":"1974","unstructured":"Saxena PR (1974) Selective vasoconstriction in carotid vascular bed by methysergide: possible relevance to its anti-migraine action. Eur J Pharmacol 27:99\u2013105","journal-title":"Eur J Pharmacol"},{"key":"BF00319734_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1526-4610.1974.hed1304142.x","volume":"13","author":"PR Saxena","year":"1974","unstructured":"Saxena PR, Vlaam-Schluter GM de (1974) Role of some biogenic substances in migraine and relevant mechanisms in antimigraine action of ergotamine. Studies in an experimental model of migraine. Headache 13:142\u2013163","journal-title":"Headache"},{"key":"BF00319734_CR20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1526-4610.1989.hed2901021.x","volume":"29","author":"D Soyka","year":"1989","unstructured":"Soyka D, Taneri Z, Oestreich W, Schmidt R (1989) Flunarizine i.v. in the acute treatment of common or classical migraine attacks. A placebo-controlled double-blind trial. Headache 29:21\u201327","journal-title":"Headache"},{"issue":"3","key":"BF00319734_CR21","first-page":"1","volume":"59","author":"P Tfelt-Hansen","year":"1986","unstructured":"Tfelt-Hansen P (1986) The effect of ergotamine on the arterial system in man (thesis). Acta Pharmacol Toxicol 59 [Suppl 3]:1\u201329","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00319734_CR22","first-page":"21","volume-title":"5-HT1-like receptor agonism as a novel approach to the treatment of acute migraine","author":"P Tfelt-Hansen","year":"1988","unstructured":"Tfelt-Hansen P (1988) Early clinical experience with subcutaneous GR43175 in acute migraine. In: Lance JW (ed) 5-HT1-like receptor agonism as a novel approach to the treatment of acute migraine. Glaxo, Greenford, Middlesex, pp 21\u201324"},{"key":"BF00319734_CR23","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/clpt.1985.7","volume":"37","author":"P Tfelt-Hansen","year":"1985","unstructured":"Tfelt-Hansen P, Paalzow L (1985) Intramuscular ergotamine: plasma levels and dynamic activity. Clin Pharmacol Ther 37:29\u201335","journal-title":"Clin Pharmacol Ther"},{"key":"BF00319734_CR24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0773.1980.tb01855.x","volume":"45","author":"P Tfelt-Hansen","year":"1980","unstructured":"Tfelt-Hansen P, Eickhoff JH, Olesen J (1980) The effect of single dose ergotamine tartrate on peripheral arteries in migraine patients: methodological aspects and time effect curve. Acta Pharmacol Toxicol 45:151\u2013156","journal-title":"Acta Pharmacol Toxicol"},{"key":"BF00319734_CR25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1526-4610.1988.hed2803183.x","volume":"28","author":"A Thie","year":"1988","unstructured":"Thie A, Spitzer K, Lachenmayer L, Kunze K (1988) Prolonged vasospasm in migraine detected by noninvasive transcranial Doppler ultrasound. Headache 28:183\u2013186","journal-title":"Headache"},{"key":"BF00319734_CR26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1526-4610.1990.hed3004209.x","volume":"30","author":"A Thie","year":"1990","unstructured":"Thie A, Fuhlendorf A, Spitzer K, Kunze K (1990) Transcranial Doppler evaluation of common and classic migraine. II. Ultrasonic features during attacks. Headache 30:209\u2013215","journal-title":"Headache"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00319734\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00319734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,26]],"date-time":"2023-11-26T21:04:37Z","timestamp":1701032677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00319734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,8]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1991,8]]}},"alternative-id":["BF00319734"],"URL":"https:\/\/doi.org\/10.1007\/bf00319734","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"type":"print","value":"0340-5354"},{"type":"electronic","value":"1432-1459"}],"subject":[],"published":{"date-parts":[[1991,8]]}}}